本页面由Tiger Trade Technology Pte. Ltd.提供服务

Castle Biosciences, Inc.

39.44
-0.1600-0.40%
盘后38.66-0.7800-1.98%19:34 EST
成交量:36.16万
成交额:1,425.76万
市值:11.51亿
市盈率:-90.84
高:39.87
开:39.46
低:39.15
收:39.60
52周最高:40.61
52周最低:14.59
股本:2,918.87万
流通股本:2,672.49万
量比:1.02
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-0.4342
每股收益(LYR):0.6569
净资产收益率:-2.69%
总资产收益率:-1.72%
市净率:2.46
市盈率(LYR):60.04

数据加载中...

2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/04/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]